Skip to content
HowShorted

CHEMBIO DIAGNOSTICS, INC. short interest in 2022

In 2022, CHEMBIO DIAGNOSTICS, INC.'s disclosed short interest ran from 7.65% of shares outstanding on 14 Jan 2022 to 5.40% on 30 Dec 2022, a change of -2.25 percentage points. The year's high was 9.22% on 14 Oct 2022 and its low 3.91% on 31 Aug 2022, averaging 6.06% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.38 days on 30 Jun 2022. Full history: CHEMBIO DIAGNOSTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for CHEMBIO DIAGNOSTICS, INC. in 2022

2022 in figures

Start of year
7.65% (14 Jan 2022)
End of year
5.40% (30 Dec 2022)
Change
-2.25 pp
High
9.22% (14 Oct 2022)
Low
3.91% (31 Aug 2022)
Average
6.06%
Highest days to cover
19.38 (30 Jun 2022)
SEC filings marked
8

Every report in 2022

CHEMBIO DIAGNOSTICS, INC. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20227.65%3.76
31 Jan 20227.25%4.46
15 Feb 20227.14%5.52
28 Feb 20226.62%6.14
15 Mar 20226.97%4.2410-K filed, results (8-K)
31 Mar 20226.47%8.10
14 Apr 20226.14%8.36
29 Apr 20225.87%8.76
13 May 20225.69%8.4810-Q filed, results (8-K)
31 May 20226.37%7.00
15 Jun 20225.62%9.56
30 Jun 20224.58%19.38
15 Jul 20224.97%14.18
29 Jul 20224.86%16.71
15 Aug 20224.84%1.00results (8-K), 10-Q filed
31 Aug 20223.91%1.00
15 Sep 20224.76%1.00
30 Sep 20226.47%4.09
14 Oct 20229.22%2.40
31 Oct 20226.51%5.08
15 Nov 20226.77%6.2910-Q filed, results (8-K)
30 Nov 20225.84%10.73
15 Dec 20225.55%8.45
30 Dec 20225.40%4.60

See also: CHEMBIO DIAGNOSTICS, INC.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.